Hap Trading, LLC Adma Biologics, Inc. Put Options Transaction History

Hap Trading, LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 14, 2023	SELL	$2.47 - $3.88 $494 - $776	-200 Reduced 0.98%	20,300 $1,000
Q3 2022 Nov 14, 2022	BUY	$2.03 - $2.86 $1,014 - $1,430	500 Added 2.5%	20,500 $8,000
Q2 2022 Aug 12, 2022	BUY	$1.43 - $2.2 $3,003 - $4,620	2,100 Added 11.73%	20,000 $11,000
Q1 2022 May 12, 2022	SELL	$1.28 - $1.83 $38,912 - $55,632	-30,400 Reduced 62.94%	17,900 $11,000
Q4 2021 Feb 14, 2022	BUY	$1.09 - $1.66 $545 - $830	500 Added 1.05%	48,300 $59,000
Q3 2021 Nov 10, 2021	SELL	$1.13 - $1.65 $225 - $330	-200 Reduced 0.42%	47,800 $74,000
Q2 2021 Aug 11, 2021	SELL	$1.51 - $2.07 $1,661 - $2,277	-1,100 Reduced 2.24%	48,000 $60,000
Q1 2021 May 14, 2021	BUY	$1.67 - $2.95 $63,293 - $111,805	37,900 Added 338.39%	49,100 $60,000
Q3 2020 Nov 13, 2020	BUY	$2.04 - $3.74 $22,848 - $41,888	11,200 New	11,200 $8,000

319

185M

917K

91.6K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $4.16B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.